Abstract:1. Three different alpha(1)-adrenoceptor subtypes, designated alpha(1A), alpha(1B) and alpha(1D), have been cloned and identified pharmacologically in cardiomyocytes. In vitro studies have suggested that alpha(1)-adrenoceptors play an important role in facilitating cardiac hypertrophy. However, it remains controversial as to which subtype of alpha(1)-adrenoceptors is involved in this response. In the present study, we investigated the different role of each alpha(1)-adrenoceptor subtype in mediating cardiomyocyte protein synthesis, which is a most important characteristic of cardiac hypertrophy in cultured neonatal rat cardiomyocytes.2. Cardiomyocyte hypertrophy was monitored by the following characteristic phenotypic changes: (i) an increase in protein synthesis; (ii) an increase in total protein content; and (iii) an increase in cardiomyocyte size.3. The role of each alpha(1)-adrenoceptor subtype in mediating cardiomyocyte protein synthesis was investigated by the effect of specific alpha(1)-adrenoceptor subtype-selective antagonists on noradrenaline-induced [H-3]-leucine incorporation. In addition, pK(B) values for alpha(1)-adrenoceptor subtype-selective antagonists were calculated and compared with the corresponding pK(i) values to further identify their effects.4. Activation of alpha(1)-adrenoceptors by phenylephrine or noradrenaline in the presence of propranolol significantly increased [H-3]-leucine incorporation, protein content and cell size.5. Pre-incubating cardiomyocytes with 5-methyl-urapidil, RS 17053 or WB 4101 significantly inhibited noradrenaline-induced [H-3]-leucine incorporation. However, there was no effect when cardiomyocytes were pre-incubated with BMY 7378. The correlation coefficients between pK(B) values for alpha(1)-adrenoceptor subtype-selective antagonists and pK(i) values obtained from cloned alpha(1A)-, alpha(1B)- or alpha(1D)-adrenoceptors were 0.92 (P < 0.01), 0.66 (P > 0.05) and 0.24 (P > 0.05), respectively.6. Our results suggest that the alpha(1)-adrenoceptor is dominantly responsible for adrenergic hypertrophy of cultured cardiomyocytes in neonatal rats. The efficiency in mediating cardiomyocyte protein synthesis is alpha(1A) > (alpha(1B) much greater than alpha(1D).

Norepinephrine regulates the in vivo expression of the L-type calcium channel

In vivo regulation of Na/Ca exchanger expression by adrenergic effectors

Modelling the Integrated Regulation Role of Β-Adrenergic Signaling and CaMKII in Human Myocyte Electrophysiological Properties

Adrenergic Stimulation Regulates Na+/Ca2+Exchanger Expression in Rat Cardiac Myocytes

Different Roles Of Alpha(1)-Adrenoceptor Subtypes In Mediating Cardiomyocyte Protein Synthesis In Neonatal Rats

Norepinephrine Induces the Raf -1 Kinase/Mitogen-Activated Protein Kinase Cascade Through Both Α 1 - and Β-Adrenoceptors

Gene Expression Profile of Cardiomyocytes in Hypertrophic Heart Induced by Continuous Norepinephrine Infusion in the Rats

The Role of Inos-Derived NO in the Antihypertrophic Actions of B-type Natriuretic Peptide in Neonatal Rat Cardiomyocytes

[Effects of Beta-Adrenoceptor Activation on Metabolism in Neonatal Rat Cardiomyocytes].

Receptor Subtype Involved in Α 1 -Adrenergic Receptor-Mediated Ca 2+ Signaling in Cardiomyocytes

Sustained Norepinephrine Stimulation Induces Different Regulation of Expression in Three Alpha(1)-Adrenoceptor Subtypes

Transcriptional Upregulation of Calcineurin Aβ by Endothelin-1 is Partially Mediated by Calcium/calmodulin-Dependent Protein Kinase IIδ3 in Rat Cardiomyocytes

β-Adrenergic Receptor Stimulation Maintains NCX-CaMKII Axis and Prevents Overactivation of IL6R-Signaling in Cardiomyocytes upon Increased Workload

ENDOGENOUS CATECHOLAMINE PARTICIPATES IN THE ACTION OF INTERLEUKIN-2 ON THE ISOLATED RAT HEART

Differential Downregulation of β1-Adrenergic Receptor Signaling in the Heart

Differential Expression of Components of the Cardiomyocyte Adrenomedullin/Intermedin Receptor System following Blood Pressure Reduction in Nitric Oxide-Deficient Hypertension

Modulation of L-type Ca2 + channels by neuromedin B in adult rat ventricular myocytes and the underlying mechanisms

Transgenic Manipulation of Beta-Adrenergic Receptor Kinase Modifies Cardiac Myocyte Contraction to Norepinephrine.

Presynaptic modulation of the norepinephrine-induced beta-adrenergic receptor desensitization phenomenon in vivo

Intracellular β1-Adrenergic Receptors and Organic Cation Transporter 3 Mediate Phospholamban Phosphorylation to Enhance Cardiac Contractility

Norepinephrine Reversibly Regulates the Proliferation and Phenotypic Transformation of Vascular Smooth Muscle Cells